INTERNATIONAL PATENT: DAEWOONG PHARMACEUTICAL CO., LTD., 주식회사 대웅제약 FILES APPLICATION FOR "SUSTAINED-RELEASE MICROSPHERES COMPRISING ROPIVACAINE AND NONSTEROIDAL ANTI-INFLAMMATORY AGENT AND PREPARATION METHOD THEREFOR"

GENEVA, Nov. 18 -- DAEWOONG PHARMACEUTICAL CO., LTD. (35-14 Jeyakgongdan 4-gil, Hyangnam-eup,Hwaseong-si,Gyeonggi-do 18623), 주식회사 대웅제약 (경기도화성시향남읍 제약공단4길 35-14) filed a patent application (PCT/KR2025/006256) for "SUSTAINED-RELEASE MICROSPHERES COMPRISING ROPIVACAINE AND NONSTEROIDAL ANTI-INFLAMMATORY AGENT, AND PREPARATION METHOD THEREFOR" on May 09, 2025. With publication no. WO/2025/234824, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed ...